Patient safety and public health concerns: poor dissolution rate of pioglitazone tablets obtained from China, Myanmar and internet sites.
Mohammad Sofiqur RahmanNaoko YoshidaHirohito TsuboiErina MaedaAndrea Vanessa Velasco IbarraTheingi ZinYoshio AkimotoTsuyoshi TanimotoKazuko KimuraPublished in: BMC pharmacology & toxicology (2021)
Despite the apparent satisfactory outcome on the samples from China, pioglitazone samples collected in Myanmar and purchased online for personal import into Japan included many substandard products, which failed quality assessment predominantly because of poor dissolution. Internet providers did not comply with Japanese regulations in various respects.